Blicklé, J-F <br/><br/>
Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study.  [electronic resource] 

 -  Diabetes, obesity & metabolism  Apr 2009 
 - 379-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/j.1463-1326.2008.00980.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Blood Glucose--metabolism<br/>Combined Modality Therapy<br/>Diabetes Mellitus, Type 2--blood<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--administration & dosage<br/>Insulin--administration & dosage<br/>Insulin Glargine<br/>Insulin, Long-Acting<br/>Life Style<br/>Middle Aged<br/>Treatment Outcome